Catalyst Pharmaceuticals
Ylse Martinez is an accomplished accounting professional with extensive experience in accounts payable management. Currently serving as an Accounts Payable Supervisor at Catalyst Pharmaceuticals, Inc. since August 2019, Ylse previously held the position of Accounts Payable at TAURUS INTERNATIONAL MFG and served as Accounts Payable Supervisor at TUUCI for a decade. Earlier in the career, Ylse worked as a Senior Payroll Specialist at MasTec Network Solutions. Ylse holds a Bachelor of Science in Business Administration with a focus on Accounting and Related Services from Isaac Newton, achieved between 1990 and 1995.
This person is not in any teams
Catalyst Pharmaceuticals
2 followers
Catalyst Pharmaceuticals is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipeline of cutting-edge, first- or best-in-class medicines for other rare diseases. Catalyst's New Drug Application for FIRDAPSE® (amifampridine) Tablets 10 mg for the treatment of adults with Lambert-Eaton myasthenic syndrome ("LEMS") was approved in 2018 by the U.S. Food & Drug Administration ("FDA"), and FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. Further, Canada's national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.